Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 2001, p. 260-270, Vol. 21, No. 1
Department of
Pathology,1 Division of
Hematology-Oncology,3 and Division of
Research Immunology/BMT,4 Childrens
Hospital Los Angeles Research Institute, Los Angeles, California 90027, and University of Southern California Keck School of
Medicine, Los Angeles, California 900332
Received 10 May 2000/Returned for modification 13 July
2000/Accepted 4 October 2000
The cyclin-dependent kinase (CDK)-activating kinase (CAK) is
involved in cell cycle control, transcription, and DNA repair (E. A. Nigg, Curr. Opin. Cell. Biol. 8:312-317, 1996). However, the
mechanisms of how CAK is integrated into these signaling pathways remain unknown. We previously demonstrated that abrogation of MAT1
(ménage à trois 1), an assembly factor and targeting
subunit of CAK, induces G1 arrest (L. Wu, P. Chen, J. J. Hwang, L. W. Barsky, K. I. Weinberg, A. Jong, and V. A. Starnes, J. Biol. Chem. 274:5564-5572, 1999). This result led
us to investigate how deregulation of CAK by MAT1 abrogation affects
the cell cycle G1 exit, a process that is regulated most
closely by phosphorylation of retinoblastoma tumor suppressor protein
(pRb). Using mammalian cellular models that undergo G1
arrest evoked by antisense MAT1 abrogation, we found that deregulation
of CAK inhibits pRb phosphorylation and cyclin E expression, CAK
phosphorylation of pRb is MAT1 dose dependent but cyclin D1/CDK4
independent, and MAT1 interacts with pRb. These results suggest that
CAK is involved in the regulation of cell cycle G1 exit
while MAT1-modulated CAK formation and CAK phosphorylation of pRb may
determine the cell cycle specificity of CAK in G1 progression.
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.1.260-270.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
MAT1-Modulated CAK Activity Regulates Cell Cycle
G1 Exit
*
Corresponding author. Mailing address: Department of
Pathology, Childrens Hospital Los Angeles Research Institute/University of Southern California Keck School of Medicine, Smith Research Tower,
MS#103, 4650 Sunset Blvd., Los Angeles, CA 90027. Phone: (323)
660-2450, ext. 6318. Fax: (323) 671-3669. E-mail:
lingtaow{at}hsc.usc.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|